|
|
|
AMGN Forecast
Recent AMGN Price |
|
AMGN Forecast Price |
$269.98 |
+12.40% |
$303.45 |
As of 2024-04-29
Recent AMGN Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
11 |
11 |
11 |
11 |
Buy ratings: |
1 |
1 |
1 |
1 |
Hold ratings: |
10 |
10 |
9 |
8 |
Sell ratings: |
0 |
0 |
0 |
0 |
Strong sell ratings: |
3 |
3 |
3 |
3 |
Average rating: |
2.32 |
2.32 |
2.29 |
2.26 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
For the Amgen Inc forecast (traded under symbol AMGN) for one year forward price target at the top of this page, we have presented the average AMGN forecast for forward target price across the 22 analysts covering AMGN, as reported in
data provided by Zacks Investment Research via Quandl.com.
Meanwhile, note that the
median AMGN forecast price target (median being the middle where half of analysts had a higher AMGN forecast and half had a lower AMGN forecast, which is a different metric than the average or mean) was $320.0 as of 2024-04-29, while the
highest AMGN forecast in the analyst group was $380.0, and the lowest AMGN forecast in the analyst group was
$185.0, with a standard deviation of $51.877. Get the latest Zacks research report on AMGN — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Name: |
Amgen Inc |
Stock buyback: |
AMGN buyback |
Website: |
www.amgen.com |
Sector: |
Biotechnology |
Number of ETFs Holding AMGN: |
134 (see which ones) |
Total Market Value Held by ETFs: |
$23,526,881,747.39 |
Total Market Capitalization: |
$146,311,000,000 |
% of Market Cap. Held by ETFs: |
16.08% |
|
|
|
|
Buy (2.68 out of 4)
20th percentile
|
|
|